The research work in our group has led to the following patents:
- Noble metal nanoparticles and their preparation process: concepts and protocols for the synthesis of highly complex metallic hollow nanostructures (2011).
- Conjugates comprising nanoparticles coated with platinum containing compounds: bioconjugated gold nanoparticles with specific features for drug delivery in cancer treatment (2008).
- Immunoactivating conjugates comprising nanoparticles coated with peptides: peptide-conjugated gold nanoparticles with specific features for controlling the immune system response and vaccine delivery (2008).
For further information on licensing opportunities, please also contact the ICN2 Technology Transfer Office.